Navidea Biopharmaceuticals Inc. (NAVB) gained 5.85% or 0.02 to $0.38. It is approximately 80147 shares traded, which is 32.48% compare to the average total volume 246777. The market cap of NAVB is $61.66 million. The year to date change is -7.71%. The 52 week price range is from $0.31 to $0.85. Price of NAVB have changed 0.12% during last week. It have changed -9.21% over last month, -15.85% over last 3 months, -10.39% over last 6 months and -24.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 0.38. The 200-day Moving Averages for NAVB is 0.43. It is 13.16% above current price. The 52-week High is 0.85. It is 123.68% from the current price. The 52-week Low is 0.31. It is -18.42% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NAVB is 17.74 on 2018-01-31. Short % to float is 2.98%. There are some statistics of NAVB. It is has market cap $61.66 million. The share outstanding is 162.26 million. The average volume is 246777. The revenue is 19.45M. It has 29.23M cash and 65.58M in debt. The gross profit is 17.15M. The percent of top 15 Institution holding is 7.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -290.31%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is 438.12%.